Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.282EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.131EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.274EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.235EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.165EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.389EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.549EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.50 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.266EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.253EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.305EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.241EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.326EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.255EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.303EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.173EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.362.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.520EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.521EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.383EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.117EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.157EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.187EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used